Bladder cancer

Bladder cancers develop from the epithelial lining of the urinary bladder. cannabinoid receptors in the human bladder cancer cells could be targeted to treat the disease, but more research is needed in this field.

Epilepsy

cannabinoids have excellent therapeutic potential for the treatment of epilepsy. In the brain, the endocannabinoid system tends to keep neuronal activity wihtin acceptable boundaries.

PPARγ

PPARγ is part of the nuclear receptor family and one of the non-GPCR cannabinoid receptors. PPARγ is involved in the regulation of fat cells/adipose tissue, insulin sensitivity and inflammation.

CB2

CB2 is primarily expressed in the immune cells and tissues of the body. Like CB1, CB2 is a G protein-coupled receptor which inhibits adenylyl cyclase and consequently lowers cAMP upon activation. This, in turn, regulates many second messenger pathways.

Prostate Cancer

Prostate cancer is the development of cancer in the prostate.

Leukemia

Leukemia cancers usually begin in the bone marrow and involves abnormal white blood cell production.

Glioblastoma

Glioblastoma is a malignant brain tumor originated in brain cells called astrocytes. Glioblastoma is one of the most promising targets for cannabinoid therapy.

Cervical cancer

Cervical cancer is a type of cancer that develops from the cervix.

Breast cancer

Breast cancers develop from breast tissue. cannabinoids have anti breast cancer properties involving inhibition of cancer growth and metastasis.

Bone cancer

Bone cancers result from primary tumor invasion to bone. cannabinoids can be used to relieve bone cancer pain through their anti-inflammatory properties and also they could be used to treat cancer itself.